This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| J07AH04 | Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AH Meningococcal vaccines |
| J07AH08 | Meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated | J Antiinfectives for systemic use → J07 Vaccines → J07A Bacterial vaccines → J07AH Meningococcal vaccines |
Meningococcal serogroup W135 polysaccharide vaccine is an active ingredient of these brands:
United States (US)
Ecuador (EC)
Japan (JP)
Singapore (SG)South Africa (ZA)Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
